The PPARα/γ dual agonist chiglitazar improves insulin resistance and dyslipidemia in MSG obese rats

1. The aim of this study was to investigate the capacity of chiglitazar to improve insulin resistance and dyslipidemia in monosodium L-glutamate (MSG) obese rats and to determine whether its lipid-lowering effect is mediated through its activation of PPARα. 2. Chiglitazar is a PPARα/γ dual agonist....

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Li, Ping-Ping, Shan, Song, Chen, Yue-Teng, Ning, Zhi-Qiang, Sun, Su-Juan, Liu, Quan, Lu, Xian-Ping, Xie, Ming-Zhi, Shen, Zhu-Fang
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group 2006
Onderwerpen:
Papers
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1751868/
https://ncbi.nlm.nih.gov/pubmed/16751799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0706745
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items